Price (delayed)
$0.97
Market cap
$27.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.12
Enterprise value
-$34.51M
Aravive, Inc. is a clinical-stage oncology company developing transformative therapeutics designed to halt the progression of life-threatening diseases. Aravive is based in Houston, Texas and received a Product Development Award
There are no recent dividends present for ARAV.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.